Johanna Lempainen
Overview
Explore the profile of Johanna Lempainen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
59
Citations
1509
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Nygard L, Valta M, Laine A, Toppari J, Knip M, Veijola R, et al.
Front Genet
. 2023 Nov;
14:1248701.
PMID: 38028613
Enteroviral infections have been linked to the development of islet autoimmunity (IA) and type 1 diabetes (T1D), and the coxsackie and adenovirus receptor (CXADR) is one of the ligands used...
12.
Ilonen J, Kiviniemi M, El-Amir M, Nygard L, Harkonen T, Lempainen J, et al.
Diabetes
. 2023 Nov;
73(2):306-311.
PMID: 37934957
Article Highlights:
13.
Lamichhane S, Sen P, Dickens A, Krakstrom M, Ilonen J, Lempainen J, et al.
Front Endocrinol (Lausanne)
. 2023 Sep;
14:1211015.
PMID: 37745723
Aims/hypothesis: Appearance of multiple islet cell autoantibodies in early life is indicative of future progression to overt type 1 diabetes, however, at varying rates. Here, we aimed to study whether...
14.
Pahkuri S, Ekman I, Vandamme C, Nanto-Salonen K, Toppari J, Veijola R, et al.
Autoimmunity
. 2023 Sep;
56(1):2259118.
PMID: 37724526
We elucidated the effect of four known T1D-susceptibility associated single nucleotide polymorphism (SNP) markers in three genes (rs12722495 and rs2104286 in , rs689 in and rs2476601 in ) on CpG...
15.
Hurme A, Jalkanen P, Marttila-Vaara M, Heroum J, Jokinen H, Vara S, et al.
Front Immunol
. 2023 May;
14:1146500.
PMID: 37234151
Primary antibody deficiencies, such as common variable immunodeficiency (CVID), are heterogenous disease entities consisting of primary hypogammaglobulinemia and impaired antibody responses to vaccination and natural infection. CVID is the most...
16.
Kolehmainen P, Huttunen M, Iakubovskaia A, Maljanen S, Tauriainen S, Yatkin E, et al.
Sci Rep
. 2023 May;
13(1):8416.
PMID: 37225867
The prevalence of seasonal human coronavirus (HCoV) infections in early childhood and adults has not been well analyzed in longitudinal serological studies. Here we analyzed the changes in HCoV (229E,...
17.
Sioofy-Khojine A, Lehtonen J, Nurminen N, Laiho J, Toppari J, Veijola R, et al.
J Med Virol
. 2023 Mar;
95(4):e28707.
PMID: 36971180
This study investigated whether children with HLA-DQ-conferred risk for type 1 diabetes (T1D) have an altered immune response to the widely-used enterovirus vaccine, namely poliovirus vaccine, and whether initiation of...
18.
Knip M, Parviainen A, Turtinen M, But A, Harkonen T, Hepojoki J, et al.
Lancet Diabetes Endocrinol
. 2023 Mar;
11(4):251-260.
PMID: 36958868
Background: Some epidemiological studies have suggested an increase in incidence of type 1 diabetes during the COVID-19 pandemic, however the mechanism(s) behind such an increase have yet to be identified....
19.
Wahrmann S, Kainulainen L, Kyto V, Lempainen J
Acta Paediatr
. 2023 Mar;
112(6):1312-1318.
PMID: 36867048
Aim: The aim of the study was to describe the clinical manifestations of 22q11.2 deletion syndrome patients in the Finnish paediatric population. Methods: Nationwide registry data including all diagnoses and...
20.
Belik M, Liedes O, Vara S, Haveri A, Poysti S, Kolehmainen P, et al.
Front Immunol
. 2023 Feb;
14:1099246.
PMID: 36756112
Introduction: The prime-boost COVID-19 mRNA vaccination strategy has proven to be effective against severe COVID-19 disease and death. However, concerns have been raised due to decreasing neutralizing antibody levels after...